Your browser doesn't support javascript.
loading
Clinical utility of whole-genome sequencing in precision oncology.
Rosenquist, Richard; Cuppen, Edwin; Buettner, Reinhard; Caldas, Carlos; Dreau, Helene; Elemento, Olivier; Frederix, Geert; Grimmond, Sean; Haferlach, Torsten; Jobanputra, Vaidehi; Meggendorfer, Manja; Mullighan, Charles G; Wordsworth, Sarah; Schuh, Anna.
Afiliação
  • Rosenquist R; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; Department of Clinical Genetics, Karolinska University Hospital, Solna, Sweden.
  • Cuppen E; Hartwig Medical Foundation, Amsterdam, The Netherlands; Center for Molecular Medicine and Oncode Institute, University Medical Center, Utrecht, The Netherlands.
  • Buettner R; Institute of Pathology, University Hospital Cologne, Germany.
  • Caldas C; Cancer Research UK Cambridge Institute and Department of Oncology, University of Cambridge, United Kingdom.
  • Dreau H; NIHR Oxford Biomedical Research Centre and Department of Oncology, University of Oxford, Oxford, United Kingdom.
  • Elemento O; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, United States; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, United States.
  • Frederix G; Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, The Netherlands.
  • Grimmond S; Centre for Cancer Research, University of Melbourne, Melbourne, Australia.
  • Haferlach T; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Jobanputra V; New York Genome Center, 101 Avenue of the Americas, New York, NY 100132, United States; Columbia University Medical Center, 650 W 168th St, New York, NY 10032, United States.
  • Meggendorfer M; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, United States.
  • Wordsworth S; Nuffield Department of Population Health and Oxford NIHR Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
  • Schuh A; NIHR Oxford Biomedical Research Centre and Department of Oncology, University of Oxford, Oxford, United Kingdom. Electronic address: anna.schuh@oncology.ox.ac.uk.
Semin Cancer Biol ; 84: 32-39, 2022 09.
Article em En | MEDLINE | ID: mdl-34175442
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article